Mirion Technologies Joins Influential Nuclear Energy Organizations to Further Bolster Nuclear Initiatives

Mirion joins the Nuclear Energy Institute, enhances membership with the American Nuclear Society as a Trustees of Nuclear partner.

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced that it has joined the Nuclear Energy Institute (NEI) and the American Nuclear Society’s (ANS) Trustees of Nuclear program. Membership in the two preeminent nuclear industry and professional organizations in the United States provides Mirion Technologies with an enhanced platform to engage with industry leaders and policymakers, as well as share industry expertise, on issues of importance to the nuclear sector.

NEI is the policy organization of the nuclear energy industry in the United States, representing the interests of the industry before Congress, the administration, and state and local governments. With its NEI membership, Mirion will participate in policy discussions that shape the nuclear industry and advocate for policies that support the growth of nuclear energy for the greater good of humanity.

ANS is the premier international professional organization of engineers, scientists, technologists, teachers, and healthcare providers devoted to the peaceful applications of nuclear science and technology. As part of its enhanced membership in ANS, Mirion will become an ANS Trustee of Nuclear and serve on its leadership council.

"As one of the only companies uniquely present across the full span of the nuclear landscape, we have an important role to play in the Nuclear Renaissance. We are thrilled to build upon our bonds with the Nuclear Energy Institute and the American Nuclear Society,” said Mirion CEO Thomas Logan. “These memberships underscore our commitment to advancing the nuclear industry and continued collaboration with leading experts and organizations. We look forward to contributing to the innovative solutions and best practices that will shape the future of nuclear energy."

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at https://www.mirion.com/.